Methylation of Dickkopf-3 as a prognostic factor in cirrhosis-related hepatocellular carcinoma.
Methylation of Dickkopf-3 as a prognostic factor in cirrhosis-related hepatocellular carcinoma.
复制标题
DOI:
10.3748/wjg.v16.i6.755
复制
发表时间:
2010-02
影响因子:
4.3
通讯作者:
Bin Yang;Z. Du;Yingtang Gao;Cheng Lou;Shi-guang Zhang;T. Bai;Yi-jun Wang;Wen-qin Song
中科院分区:
文献类型:
--
作者:
Bin Yang;Z. Du;Yingtang Gao;Cheng Lou;Shi-guang Zhang;T. Bai;Yi-jun Wang;Wen-qin Song
AIM To investigate the prevalence and time of Dickkopf (DKK) family methylation and its clinical significance in hepatocarcinogenesis. METHODS Methylation of DKK family genes was quantitatively analyzed in 115 liver tissue samples, including 50 pairs of primary hepatocellular carcinoma (HCC) and matched noncancerous cirrhotic tissue samples, as well as 15 liver cirrhosis biopsy samples. RESULTS The methylation level of DKK3 was significantly higher in HCC tissue samples than in matched noncancerous cirrhotic tissue samples (P 1%) was significantly shorter than that of those with a lower DKK3 methylation level (PMR < or = 1%) (P = 0.0255). Multivariate Cox analysis indicated that methylated DKK3 was significantly and independently related with a shorter survival time (relative risk = 2.527, 95% CI: 1.063-6.008, P = 0.036) of HCC patients. CONCLUSION Methylation of DKK3 is an important event in early malignant transformation and HCC progression, and therefore might be a prognostic indicator for risk assessment of HCC.